DB00171 | ATP | investigational, nutraceutical | unknown | inhibitor | Details |
DB00619 | Imatinib | approved | yes | inhibitor | Details |
DB01254 | Dasatinib | approved, investigational | yes | inhibitormultitarget | Details |
DB04868 | Nilotinib | approved, investigational | yes | inhibitor | Details |
DB05184 | XL228 | investigational | unknown | | Details |
DB07831 | 2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE | experimental | unknown | | Details |
DB08043 | 1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA | experimental | unknown | | Details |
DB08231 | Myristic acid | experimental | unknown | | Details |
DB08339 | PD-166326 | experimental | unknown | | Details |
DB08350 | 5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE | experimental | unknown | | Details |
DB03878 | N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide | experimental | unknown | | Details |
DB08583 | 2-amino-5-[3-(1-ethyl-1H-pyrazol-5-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-N,N-dimethylbenzamide | experimental | unknown | | Details |
DB08896 | Regorafenib | approved | yes | inhibitor | Details |
DB06616 | Bosutinib | approved | yes | inhibitor | Details |
DB08901 | Ponatinib | approved, investigational | yes | inhibitor | Details |
DB12323 | Radotinib | investigational | yes | antagonist | Details |
DB12267 | Brigatinib | approved, investigational | unknown | inhibitor | Details |
DB13749 | Magnesium gluconate | approved, investigational | no | substrateinducer | Details |
DB12010 | Fostamatinib | approved, investigational | unknown | inhibitor | Details |
DB14989 | Umbralisib | approved, investigational, withdrawn | unknown | inhibitor | Details |
DB14989 | Umbralisib | approved, investigational, withdrawn | unknown | inhibitor | Details |
DB12597 | Asciminib | approved, investigational | yes | inhibitorallosteric modulator | Details |